ORM-15341

CAS No. 1297537-33-7

ORM-15341( —— )

Catalog No. M11200 CAS No. 1297537-33-7

The active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 75 In Stock
5MG 68 In Stock
10MG 116 In Stock
25MG 188 In Stock
50MG 296 In Stock
100MG 444 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ORM-15341
  • Note
    Research use only, not for human use.
  • Brief Description
    The active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor.
  • Description
    The active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor; inhibits wtAR/AR(F876L) with IC50s of 25/51 nM respectively; suppresses androgen-induced cell proliferation more efficaciously than enzalutamide or ARN-509.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor (AR)
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    1297537-33-7
  • Formula Weight
    396.8303
  • Molecular Formula
    C19H17ClN6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 37 mg/mL
  • SMILES
    CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=CC(=NN3)C(=O)C
  • Chemical Name
    1H-Pyrazole-3-carboxamide, 5-acetyl-N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Moilanen AM, et al. Sci Rep. 2015 Jul 3;5:12007.
molnova catalog
related products
  • RD162

    RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM.

  • ARN-509

    ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM in a cell-free assay, useful for prostate Y treatment.

  • BMS-641988 B

    BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.